Phil Spinella: Blood is for Bleeding, Salt Water is for Cooking pasta, Keeping It Simple
Phil Spinella, Co-Director, Trauma and Transfusion Medicine Research Center at the University of Pittsburgh, shared JAMA Surgery‘s post on LinkedIn:
“Blood is for Bleeding. Salt water is for cooking pasta. Keeping it simple …..
The title says hemorrhagic shock. Thats the population being discussed not minor or even moderate bleeding.”
JAMA Surgery shared a post on LinkedIn about a recent article by Julia R. Coleman et al., adding:
“Viewpoint: In hemorrhagic shock, large-volume crystalloid administration may worsen dilutional coagulopathy, hypothermia, metabolic acidosis, and other physiologic disturbances, while blood-based resuscitation aligns more closely with contemporary damage control principles.
The Viewpoint indicates that future evidence reviews should better account for pragmatic trauma trial design, transfer status, transport time, and patient selection when assessing prehospital blood transfusion.”
Title: Blood or Crystalloids for Hemorrhagic Shock—Response to the Agency for Healthcare Research and Quality
Authors: Julia R. Coleman, Reynold Henry, Nakul Raykar, John B. Holcomb

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?
-
Nov 15, 2026, 15:53Nicolas Schommer: The Seed and Soil Hypothesis of NET-Mediated Inflammation
-
Nov 15, 2026, 15:36Giovanni Merlino: Targeting LDL-C to Prevent Recurrent Stroke
-
Nov 15, 2026, 15:33Riitta Lassila: From Helsinki to ISTH 2027 Advancing Thrombosis Research
-
Nov 15, 2026, 15:30Andreas Calatzis: Can Protein C and Plasma Overcome Fibrinolysis Resistance in Sepsis?
-
Nov 15, 2026, 15:25Hussnain Javaid: Thalassaemia 2026 New Therapies Transforming UK Practice